Drug Type mRNA |
Synonyms- |
Target |
Mechanism EGFR agonists(Epidermal growth factor receptor erbB1 agonists), c-Met agonists(Hepatocyte growth factor receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Nonalcoholic Steatohepatitis | Preclinical | US | - | |
Nonalcoholic Steatohepatitis | Preclinical | US | - |